Tutorials
NAS:MIST (Canada)  
Milestone Pharmaceuticals Inc logo

Milestone Pharmaceuticals Inc

$ 6.89 +0.09 (+1.32%) 10:08 PM EST
P/E:
At Loss
P/B:
2.05
Market Cap:
$ 206.17M
Enterprise V:
$ 106.56M
Volume:
130.33K
Avg Vol (2M):
73.63K
Volume:
130.33K
Market Cap $:
206.17M
PE Ratio:
At Loss
Avg Vol (2-Month):
73.63K
Enterprise Value $:
106.56M
PB Ratio:
2.05
GF Score:
Year:
EMBED
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website SEC Filings Stock Report
Dataset
Financial Download Tutorials

Business Description

Milestone Pharmaceuticals Inc
NAICS : 325412 SIC : 3741
1111 Dr. Frederik-Philips Boulevard, Suite 420, Montreal, QC, CAN, H4M 2X6
Description
Milestone Pharmaceuticals Inc is a biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular indications. Etripamil is a calcium channel blocker developed as a rapid-onset nasal spray to be administered by the patient to terminate episodes of paroxysmal supraventricular tachycardia, or PSVT.
Name Current Vs Industry Vs History
Cash-To-Debt 158.86
Equity-to-Asset 0.95
Debt-to-Equity 0.01
Debt-to-EBITDA -0.01
Interest Coverage N/A
N/A
N/A
Piotroski F-Score 5/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 21.51
Distress
Grey
Safe
Beneish M-Score 0
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Growth Rank

Name Current Vs Industry Vs History
3-Year EBITDA Growth Rate -0.7
3-Year EPS without NRI Growth Rate -1.3
3-Year FCF Growth Rate 3.7
Name Current Vs Industry Vs History
5-Day RSI 43.43
9-Day RSI 51.47
14-Day RSI 55.08
6-1 Month Momentum % -7.89
12-1 Month Momentum % 7.62

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 22.77
Quick Ratio 22.77
Cash Ratio 21.74

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -8.9

Financials (Next Earnings Date:2022-08-11 Est.)

MIST's 30-Y Financials

Guru Trades

See Details
To
EMBED
SAVE

Insider Trades

See Details
To
EMBED
SAVE

Gurus Latest Trades with NAS:MIST

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
EMBED
SAVE
Dividend
To
EMBED
SAVE

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

EMBED

Valuation Box

Year:
EMBED

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 15
EPS (TTM) ($) -1.05
Beta 2.76
Volatility % 55.94
14-Day RSI 55.08
14-Day ATR ($) 0.449861
20-Day SMA ($) 6.78675
12-1 Month Momentum % 7.62
52-Week Range ($) 3.9801 - 8.24
Shares Outstanding (Mil) 29.92

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 5
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Milestone Pharmaceuticals Inc Filings

Document Form Filing Date
No Filing Data

Headlines

See More